Corilagin Interferes With Toll-Like Receptor 3-Mediated Immune Response in Herpes Simplex Encephalitis

Herpes simplex encephalitis (HSE) is the most common infectious disease of the central nervous system worldwide. However, the pathogenesis of HSE is not clear. Research has shown that the immune response mediated by the toll-like receptor 3 (TLR3) signaling pathway is essential to protect the centra...

Full description

Bibliographic Details
Main Authors: Lu-Jun Li, Shao-Jun Zhang, Pan Liu, You-Qin Wang, Zhi-Lin Chen, Yu-Jie Wang, Jia-Bin Zhou, Yuan-Jin Guo, Lei Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnmol.2019.00083/full
_version_ 1798046067788349440
author Lu-Jun Li
Shao-Jun Zhang
Pan Liu
You-Qin Wang
Zhi-Lin Chen
Yu-Jie Wang
Jia-Bin Zhou
Yuan-Jin Guo
Lei Zhao
author_facet Lu-Jun Li
Shao-Jun Zhang
Pan Liu
You-Qin Wang
Zhi-Lin Chen
Yu-Jie Wang
Jia-Bin Zhou
Yuan-Jin Guo
Lei Zhao
author_sort Lu-Jun Li
collection DOAJ
description Herpes simplex encephalitis (HSE) is the most common infectious disease of the central nervous system worldwide. However, the pathogenesis of HSE is not clear. Research has shown that the immune response mediated by the toll-like receptor 3 (TLR3) signaling pathway is essential to protect the central nervous system against herpes simplex virus (HSV) infection. However, an excessive immune response may cause tissue damage accompanied by pathological changes. The aim of this study was to explore the molecular mechanism via which corilagin controls HSE through the TLR3 signaling pathway in vitro and in vivo. Cells and mice were pre-treated with polyriboinosinic polyribocytidylic acid [poly(I:C)] or HSV type 1, and then treated with corilagin. After treatment, the mRNA and protein levels of TLR3, TLR-like receptor-associated interferon factor (TRIF), tumor necrosis factor (TNF) receptor type 1-associated DEATH domain protein (TRADD), TNF receptor-associated factor (TRAF) 3 and 6, nuclear factor-kappa-B (NF-κB) essential modulator (NEMO), P38, and interferon regulatory factor 3 (IRF3) were decreased. Interleukin-6 (IL-6), TNF-α, and type 1 interferon-β were also decreased. When TLR3 expression was silenced or increased, corilagin still inhibited the expression of TLR3 and its downstream mediators. Hematoxylin-eosin (HE) staining and immunohistochemical examinations of mouse brain tissues revealed that corilagin lessened the degree of brain inflammation. Altogether, these results suggest that corilagin may regulate the immune response in HSE and relieve inflammatory injury by interfering with the TLR3 signaling pathway.
first_indexed 2024-04-11T23:31:36Z
format Article
id doaj.art-b2444baab28f41c09fc6a19d46b4f8c8
institution Directory Open Access Journal
issn 1662-5099
language English
last_indexed 2024-04-11T23:31:36Z
publishDate 2019-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Neuroscience
spelling doaj.art-b2444baab28f41c09fc6a19d46b4f8c82022-12-22T03:57:07ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992019-04-011210.3389/fnmol.2019.00083432913Corilagin Interferes With Toll-Like Receptor 3-Mediated Immune Response in Herpes Simplex EncephalitisLu-Jun Li0Shao-Jun Zhang1Pan Liu2You-Qin Wang3Zhi-Lin Chen4Yu-Jie Wang5Jia-Bin Zhou6Yuan-Jin Guo7Lei Zhao8National & Local Joint Engineering Research Center of High-throughput Drug Screening Technology, State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei University, Wuhan, ChinaNational & Local Joint Engineering Research Center of High-throughput Drug Screening Technology, State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei University, Wuhan, ChinaSchool of Clinical Medicine, Hubei University of Chinese Medicine, Wuhan, ChinaRenmin Hospital of Hubei University of Medicine, The Postgraduate Training Center of Jinzhou Medical University, Shiyan, ChinaDepartment of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Neurosurgery, Affiliated Hospital of Jining Medical University and Shangdong Provincial Key Laboratory of Stem Cells and Neuro-Oncology, Jining, ChinaDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHerpes simplex encephalitis (HSE) is the most common infectious disease of the central nervous system worldwide. However, the pathogenesis of HSE is not clear. Research has shown that the immune response mediated by the toll-like receptor 3 (TLR3) signaling pathway is essential to protect the central nervous system against herpes simplex virus (HSV) infection. However, an excessive immune response may cause tissue damage accompanied by pathological changes. The aim of this study was to explore the molecular mechanism via which corilagin controls HSE through the TLR3 signaling pathway in vitro and in vivo. Cells and mice were pre-treated with polyriboinosinic polyribocytidylic acid [poly(I:C)] or HSV type 1, and then treated with corilagin. After treatment, the mRNA and protein levels of TLR3, TLR-like receptor-associated interferon factor (TRIF), tumor necrosis factor (TNF) receptor type 1-associated DEATH domain protein (TRADD), TNF receptor-associated factor (TRAF) 3 and 6, nuclear factor-kappa-B (NF-κB) essential modulator (NEMO), P38, and interferon regulatory factor 3 (IRF3) were decreased. Interleukin-6 (IL-6), TNF-α, and type 1 interferon-β were also decreased. When TLR3 expression was silenced or increased, corilagin still inhibited the expression of TLR3 and its downstream mediators. Hematoxylin-eosin (HE) staining and immunohistochemical examinations of mouse brain tissues revealed that corilagin lessened the degree of brain inflammation. Altogether, these results suggest that corilagin may regulate the immune response in HSE and relieve inflammatory injury by interfering with the TLR3 signaling pathway.https://www.frontiersin.org/article/10.3389/fnmol.2019.00083/fullcorilaginherpes simplex virus type 1inflammationsignaling pathwaytoll-like receptor 3
spellingShingle Lu-Jun Li
Shao-Jun Zhang
Pan Liu
You-Qin Wang
Zhi-Lin Chen
Yu-Jie Wang
Jia-Bin Zhou
Yuan-Jin Guo
Lei Zhao
Corilagin Interferes With Toll-Like Receptor 3-Mediated Immune Response in Herpes Simplex Encephalitis
Frontiers in Molecular Neuroscience
corilagin
herpes simplex virus type 1
inflammation
signaling pathway
toll-like receptor 3
title Corilagin Interferes With Toll-Like Receptor 3-Mediated Immune Response in Herpes Simplex Encephalitis
title_full Corilagin Interferes With Toll-Like Receptor 3-Mediated Immune Response in Herpes Simplex Encephalitis
title_fullStr Corilagin Interferes With Toll-Like Receptor 3-Mediated Immune Response in Herpes Simplex Encephalitis
title_full_unstemmed Corilagin Interferes With Toll-Like Receptor 3-Mediated Immune Response in Herpes Simplex Encephalitis
title_short Corilagin Interferes With Toll-Like Receptor 3-Mediated Immune Response in Herpes Simplex Encephalitis
title_sort corilagin interferes with toll like receptor 3 mediated immune response in herpes simplex encephalitis
topic corilagin
herpes simplex virus type 1
inflammation
signaling pathway
toll-like receptor 3
url https://www.frontiersin.org/article/10.3389/fnmol.2019.00083/full
work_keys_str_mv AT lujunli corilagininterfereswithtolllikereceptor3mediatedimmuneresponseinherpessimplexencephalitis
AT shaojunzhang corilagininterfereswithtolllikereceptor3mediatedimmuneresponseinherpessimplexencephalitis
AT panliu corilagininterfereswithtolllikereceptor3mediatedimmuneresponseinherpessimplexencephalitis
AT youqinwang corilagininterfereswithtolllikereceptor3mediatedimmuneresponseinherpessimplexencephalitis
AT zhilinchen corilagininterfereswithtolllikereceptor3mediatedimmuneresponseinherpessimplexencephalitis
AT yujiewang corilagininterfereswithtolllikereceptor3mediatedimmuneresponseinherpessimplexencephalitis
AT jiabinzhou corilagininterfereswithtolllikereceptor3mediatedimmuneresponseinherpessimplexencephalitis
AT yuanjinguo corilagininterfereswithtolllikereceptor3mediatedimmuneresponseinherpessimplexencephalitis
AT leizhao corilagininterfereswithtolllikereceptor3mediatedimmuneresponseinherpessimplexencephalitis